Tradestie Institutional Equity Comparison Engine
GLPG vs BHST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GLPG Overall Edge
GLPG Captures Institutional Edge (4โ0 Pillars ยท 9โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Galapagos NV (GLPG) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, GLPG trades at N/M Forward P/E with 88.0% operating margin (+1093.2% YoY revenue) versus BHST at N/M Forward P/E and -18.0% operating margin (+3.8% YoY). In options structure, GLPG sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro) against BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
GLPG
GLPG N/M vs BHST N/M Fwd P/E
Growth & Margin Winner
GLPG
Op Margin 88.0% vs -18.0% ยท YoY +1093.2% vs +3.8%
Momentum & Technical Winner
GLPG
1Y +5.6% vs -79.4% ยท 52W Pos 23% vs 6%
Options & Structure Winner
GLPG
UNCLASSIFIED (2nd %ile IV) vs UNCLASSIFIED (N/A IV)
GLPG
NASDAQ
Galapagos NV
Pharmaceutical Preparations
$27.73
-3.75% 1D
Market Cap
$1.9B
1M Return
-4.02%
1Y Return
+5.56%
Forward P/E
N/M
Unified AI Score
61.5 / 100
BUY
Tech 45.0
Fund 52.0
Flow 50.0
Mom 64.0
BHST
NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap
$29.9M
1M Return
-22.62%
1Y Return
-79.4%
Forward P/E
N/M
Unified AI Score
58.2 / 100
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
GLPG +5.56%
BHST -79.4%
Spread: +25.82 pp (GLPG Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
GLPG TTM Op. Margin: 88.0%
BHST TTM Op. Margin: -18.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GLPG vs BHST. Trailing 12-month operating profitability (GLPG 88.0% vs BHST -18.0%) and valuation multiples (GLPG N/M vs BHST N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GLPG | BHST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.9B | $29.9M | Larger Scale | GLPG |
| Trailing P/E Ratio Valuation | 5.1x | N/M | Lower Multiple | GLPG |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +1093.2% | +3.8% | Higher Growth | GLPG |
| Operating Margin (TTM) Profitability | 88.0% | -18.0% | Higher Margin | GLPG |
| Net Profit Margin Profitability | 28.8% | -31.2% | Higher Margin | GLPG |
| Return on Equity (ROE) Capital Efficiency | 10.4% | -142.5% | Higher ROE | GLPG |
| 52-Week Range Position Momentum | 23% ($25โ$38) | 6% ($1โ$7) | Stronger Trend | GLPG |
| Beta / 30D Volatility Risk Regime | 0.71ฮฒ ยท 20% Vol | 0.25ฮฒ ยท 86% Vol | Lower Realized Risk | GLPG |
| Unified Institutional Score Composite Signal | 61.5 / 100 (BUY) | 58.2 / 100 (HOLD) | Higher Composite | GLPG |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full GLPG vs BHST Buy Guide
GLPG
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
BHST
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither GLPG nor BHST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.